Algert Global’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.44M Sell
180,430
-42,410
-19% -$981K 0.05% 581
2026
Q1
$5.33M Buy
222,840
+182,740
+456% +$4.47M 0.08% 423
2025
Q4
$907K Buy
+40,100
New +$873K 0.01% 865
2025
Q1
Sell
-289,713
Closed -$3.51M 1216
2024
Q4
$3.51M Buy
289,713
+28,955
+11% +$379K 0.08% 408
2024
Q3
$3.83M Sell
260,758
-1,540
-0.6% -$21.5K 0.1% 338
2024
Q2
$3.78M Buy
262,298
+48,358
+23% +$773K 0.13% 257
2024
Q1
$3.48M Buy
213,940
+44,670
+26% +$698K 0.14% 254
2023
Q4
$2.52M Buy
169,270
+117,130
+225% +$1.33M 0.1% 338
2023
Q3
$586K Sell
52,140
-256,030
-83% -$2.97M 0.03% 696
2023
Q2
$3.1M Buy
+308,170
New +$2.86M 0.13% 232

Other funds holding ELAN

Algert Global's ELAN Position: Q2 2026 in Review

Algert Global reduced its Elanco Animal Health (ELAN) stake by 19% in Q2 2026, selling an estimated $981K and leaving 180,430 shares worth $4.44M. The position accounts for 0.05% of the portfolio, ranked #581.

Algert Global first reported a position in ELAN in Q2 2023 and has held it in 10 quarters since. The position peaked at $5.33M in Q1 2026. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Algert Global held 180,430 shares of Elanco Animal Health worth $4.44M as of Q2 2026.
  • Algert Global sold 42,410 Elanco Animal Health shares in Q2 2026, an estimated $981K.
  • Elanco Animal Health made up 0.05% of Algert Global's portfolio in Q2 2026, its #581 holding.
  • Algert Global first reported a position in Elanco Animal Health in Q2 2023 and has held it in 10 quarters since.
  • Algert Global's Elanco Animal Health position peaked at $5.33M in Q1 2026.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.